Demonstration of myositis ossificans by 99mTc pyrophosphate bone scanning
- PMID: 4364158
- DOI: 10.1148/111.3.663
Demonstration of myositis ossificans by 99mTc pyrophosphate bone scanning
Similar articles
-
Myositis ossificans: radiologic evaluation of two cases with diagnostic computed tomograms.Clin Orthop Relat Res. 1982 Aug;(168):187-91. Clin Orthop Relat Res. 1982. PMID: 6286203
-
Technetium-99m labeled agents for skeletal imaging.CRC Crit Rev Clin Radiol Nucl Med. 1976;8(1):1-31. CRC Crit Rev Clin Radiol Nucl Med. 1976. PMID: 789010 Review.
-
Myositis ossificans and the three-phase bone scan.AJR Am J Roentgenol. 1984 Jan;142(1):179-80. doi: 10.2214/ajr.142.1.179. AJR Am J Roentgenol. 1984. PMID: 6606955 No abstract available.
-
Increased localization of 99mTc-pyrophosphate in a bone island: case report.J Nucl Med. 1976 Feb;17(02):113-5. J Nucl Med. 1976. PMID: 173815
-
The imaging of myositis ossificans.Semin Musculoskelet Radiol. 2010 Jun;14(2):201-16. doi: 10.1055/s-0030-1253161. Epub 2010 May 18. Semin Musculoskelet Radiol. 2010. PMID: 20486028 Review.
Cited by
-
Studies on the Labeling of Ethylenediaminetetramethylene Phosphonic Acid, Methylene Diphosphonate, Sodium Pyrophosphate and Hydroxyapatite with Lutetium-177 for use in Nuclear Medicine.World J Nucl Med. 2015 May-Aug;14(2):95-100. doi: 10.4103/1450-1147.155752. World J Nucl Med. 2015. PMID: 26097419 Free PMC article.
-
Bone scintigraphy of myositis ossificans in apallic syndrome.Eur J Nucl Med. 1982;7(9):426-8. doi: 10.1007/BF00256825. Eur J Nucl Med. 1982. PMID: 6215250 No abstract available.
-
Quantitative assessment of 99mTc-MDP scans in investigation of diffuse alterations in bone.Eur J Nucl Med. 1979 Dec;4(6):407-12. doi: 10.1007/BF00300836. Eur J Nucl Med. 1979. PMID: 520353 No abstract available.
-
99mTc-methylene diphosphonate and 67Ga-uptake in myositis ossificans.Eur J Nucl Med. 1986;12(5-6):311-2. doi: 10.1007/BF00251998. Eur J Nucl Med. 1986. PMID: 3780778
-
Heterotopic Ossification: A Challenging Complication of Total Hip Arthroplasty: Risk Factors, Diagnosis, Prophylaxis, and Treatment.Biomed Res Int. 2019 Apr 16;2019:3860142. doi: 10.1155/2019/3860142. eCollection 2019. Biomed Res Int. 2019. PMID: 31119167 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources